Claim and prior-art mapping
Break claims into targets, modalities, mechanisms, compositions, assays, and technical constraints that can be compared.
Purna AI helps R&D and strategy teams connect claims, prior art, mechanisms, targets, assays, and competitor activity into a clearer view of novelty and freedom-to-operate risk.

Break claims into targets, modalities, mechanisms, compositions, assays, and technical constraints that can be compared.
Review patents, papers, pathways, targets, and experimental evidence together instead of treating legal and scientific context separately.
Highlight crowded areas, weak novelty arguments, overlapping mechanisms, missing evidence, and unexplored whitespace.
Map targets, modalities, mechanisms, compositions, assays, and constraints so claim scope can be compared against the underlying biology.
Review patents, papers, targets, pathways, assays, and experimental evidence together so technical risk is grounded in science.
Organize the landscape into risk zones so teams can see where claims overlap, where evidence is thin, and where room may remain.
Produce a structured analysis with claim comparisons, citations, evidence tables, risk notes, and open questions for counsel or R&D review.
No scripting, no config files, no Slack-pinging the bioinformatics team.
“Break this claim set into targets, modalities, mechanisms, assays, and technical constraints.”
“Compare this invention against prior art and summarize the strongest novelty risks.”
“Flag patents that may overlap with this target-modality combination and explain the scientific basis.”
“Map competitor assets around this pathway and identify crowded claims versus whitespace.”
“List the experimental evidence needed to support this claim scope and where the current data is weak.”
“Draft a technical FTO memo that separates legal claim questions from scientific evidence gaps.”